Trial · NCT03733145
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Median Dose Required to Increase the Systolic Blood Pressure (SBP) | up to 1 hour | The median dose required to increase the SBP in these 3 cohorts with essential hypertension (ACE inhibitor, ARB, or those on another class of hypertensive agents) to within 5% of baseline or higher will be calculated. |
| Secondary | Median Serum Level of Bradykinin 1-8 | up to 1 hour | Median serum level of Bradykinin 1-8 |
| Secondary | Median Serum Level of Bradykinin 1-7 | Up to 1 hour | Median serum level of Bradykinin 1-7 |
| Secondary | Median Serum Level of Bradykinin 1-5 | Up to 1 hour | Median serum level of Bradykinin 1-5 |
| Secondary | Median Serum Level of Aldosterone | Up to 1 hour | Median serum level of Aldosterone |
| Secondary | Median Serum Level of Angiotensin I | Up to 1 hour | Median serum level of Angiotensin I |
| Secondary | Median Serum Level of Angiotensin II | up to 1 hour | Median serum level of Angiotensin II |
| Secondary | Median Serum Level of Angiotensin IV | Up to 1 hour | Median serum level of Angiotensin IV |
| Secondary | Median Serum Level of Angiotensin 1-7 | Up to 1 hour | Median serum level of Angiotensin 1-7 |
| Secondary | Median Serum Level of Angiotensin 1-5 | Up to 1 hour | Median serum level of Angiotensin 1-5 |
| Secondary | Median Serum Level of Angiotensin 1-9 | Up to 1 hour | Median serum level of Angiotensin 1-9 |
| Secondary | Median Serum Level of Angiotensin 2-10 | Up to 1 hour | Median serum level of Angiotensin 2-10 |
| Secondary | Median Serum Level of Angiotensin 2-7 | Up to 1 hour | Median serum level of Angiotensin 2-7 |
| Secondary | Median Serum Level of Angiotensin 3-7 | Up to 1 hour | Median serum level of Angiotensin 3-7 |
| Secondary | Median Serum Level of Angiotensin 1-12 | Up to 1 hour | Median serum level of Angiotensin 1-12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03733145/registered